Clinical Trials Directory

Trials / Completed

CompletedNCT01759706

Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy

Safety and Feasibility Study of an Enhanced Recovery After Surgery Protocol in Patients Undergoing Elective Pancreaticoduodenectomy.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
123 (actual)
Sponsor
Università Vita-Salute San Raffaele · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the adherence to an enhanced recovery after surgery (ERAS) pathway and the impact of the ERAS protocol on postoperative short-term outcome in patients undergoing pancreaticoduodenectomy (PD).

Detailed description

A specific enhanced recovery after surgery (ERAS) protocol has been applied since October 2010 in consecutive patients undergoing pancreaticoduodenectomy (PD) in a high volume Institution. Patient compliance for each item has been assessed. Each ERAS patient was matched with a patient who received standard perioperative care. Match criteria were age, gender, malignant / benign disease, and PD prognostic score.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEnhanced recovery after surgery protocolERAS items implemented were: preadmission counselling, preoperative immunonutrition, no preoperative bowel preparation, epidural analgesia, no pre-anesthetic medication, intraoperative iv fluid restriction, PONV and hypothermia prophylaxis, removal of nasogastric tube (NGT) at the end of surgery, mobilization protocol, solid food diet from POD 2, early stop of iv infusions and removal of urinary catheter.
PROCEDUREStandard perioperative careEpidural analgesia, pre-anesthetic medication with diazepam, bowel preparation with oral assumption of sodium phosphate, removal of nasogastric tube on POD 1, solid food diet from POD 4
DRUGPONV prophylaxis with Ondansetron + DexamethasonePostoperative nausea and vomiting prophylaxis with Ondansetron + Dexamethasone.
OTHERPostoperative mobilization programPatient mobilization for 2 hours on first postoperative day Patient mobilization for 4 hours on first postoperative day + assisted deambulation in the room Patient mobilization for 6 hours on first postoperative day + assisted deambulation in the ward
DRUGEpidural analgesia with naropin + sufentanilMidthoracic epidural analgesia with naropin 0.2 % plus sufentanil 0,5 mcg/mL
DRUGPre-anesthetic medication with diazepamPremedication before general anesthesia
BEHAVIORALPreadmission counsellingPatient multidisciplinary preoperative counselling, including anesthesiologist, surgeon and nurse.
DRUGPreoperative bowel preparation with sodium phosphatePreoperative bowel preparation with oral assumption of sodium phosphate

Timeline

Start date
2010-10-01
Primary completion
2012-12-01
Completion
2013-01-01
First posted
2013-01-03
Last updated
2014-12-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01759706. Inclusion in this directory is not an endorsement.